Literature DB >> 20380153

Restoration of expression of MHC class I molecule in Walker 256 tumor in growth dynamics in Brattleboro rats.

M A Mafanasyeva1, L A Zakharova, I I Khegai, N P Sharova, N A Popova, L N Ivanova, V I Melnikova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20380153     DOI： 10.1134/s1607672910010047

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  14 in total

1.  Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity.

Authors:  Ulrich T Hacker; Ines Schildhauer; Margarita Céspedes Barroso; David M Kofler; Franz M Gerner; Josef Mysliwietz; Hildegard Buening; Michael Hallek; Susan B S King
Journal:  Cancer Immunol Immunother       Date:  2005-07-26       Impact factor: 6.968

2.  High frequency of altered HLA class I phenotypes in invasive breast carcinomas.

Authors:  T Cabrera; M Angustias Fernandez; A Sierra; A Garrido; A Herruzo; A Escobedo; A Fabra; F Garrido
Journal:  Hum Immunol       Date:  1996-10       Impact factor: 2.850

Review 3.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

4.  Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence.

Authors:  A K Johnsen; J France; N Nagy; D Askew; F W Abdul-Karim; S L Gerson; M S Sy; C V Harding
Journal:  Int J Cancer       Date:  2001-02-01       Impact factor: 7.396

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Altered MHC class I antigens in tumors.

Authors:  I Algarra; A Collado; F Garrido
Journal:  Int J Clin Lab Res       Date:  1997

7.  Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor.

Authors:  T C Cavalcanti; C C Gregorini; F Guimarães; O Rettori; A N Vieira-Matos
Journal:  Braz J Med Biol Res       Date:  2003-06-26       Impact factor: 2.590

Review 8.  Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

Authors:  Murrium Ahmad; Robert C Rees; Selman A Ali
Journal:  Cancer Immunol Immunother       Date:  2004-06-10       Impact factor: 6.968

9.  Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.

Authors:  C M Cabrera; P Jiménez; T Cabrera; C Esparza; F Ruiz-Cabello; F Garrido
Journal:  Tissue Antigens       Date:  2003-03

10.  Walker 256 tumor growth in rats with hereditary defect of vasopressin synthesis.

Authors:  I I Khegai; N A Popova; L A Zakharova; L N Ivanova
Journal:  Bull Exp Biol Med       Date:  2006-09       Impact factor: 0.804
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.